Amgen meets analyst estimates, but shares drop on Q2 earnings decline
Amgen’s revenues climbed 6 percent in the second quarter, to $6.2 billion, despite the COVID-19 pandemic limiting hospital and physician operations and putting a hitch in diagnosis and treatment for many patients. Amgen’s earnings, announced July 28, met average analyst estimates. However, a 17 percent overall decline in net income for the Thousand Oaks biotech Read More →
Read More →Teledyne stock climbs as Q2 earnings beat analyst estimates
Second-quarter sales for Thousand Oaks-based Teledyne Technologies dipped 5 percent to $743.3 million, and net income beat analyst estimates, sending the stock up 2.5 percent in early trading. Net income fell around 10 percent compared to the previous year’s second quarter to $93.7 million, or $2.48 per share, squarely beating analyst predictions of around $2 Read More →
Read More →Amgen puts $421M into BeiGene
Thousand Oaks biotech giant Amgen has upped its investment in Chinese oncology research firm BeiGene by $421 million. Amgen’s new investment, announced July 13, will allow the company maintain its ownership interest in BeiGene at 20.3 percent following a direct offering by the Chinese firm. Amgen shares rose more than 1 percent following the news Read More →
Read More →
Amgen’s growth over 40 years key to tri-county economy
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Business Forward Ventura County new resource hub
Business Forward Ventura County, a new resource hub for the region, is launching on July 7. The new hub replaces Ventura County Grows Business, which was developed by the Workforce Development Board. Business Forward Ventura County is designed to be a place where business leaders and owners can find resources, resource providers, business associations, news Read More →
Read More →Judge upholds Amgen’s Enbrel patents
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Our view: Union Bank puts money into social equity effort
There is no doubt that the killing of George Floyd and subsequent events have prompted the biggest discussion in decades about social equity and justice in America. One of the biggest debates in Corporate America today is how far the current discussion will lead. And one of the biggest problems in getting some perspective on Read More →
Read More →
Sponsored content:
2015-2016 Giving Guide
